ANXA6 and androgen insensitivity syndrome: We identified ANXA6 as an independent risk factor for AIS outcomes (odds ratio [OR] = 2.120; 95% CI = 1.563–3.023; p < 0.001) (Figure 6F), indicating that each unit increase in ANXA6 is associated with 2.12 times higher likelihood of poor prognosis.